Literature DB >> 23477153

[Comparative study on anti-inflammatory and antipyretic effects between Dao-di herb and non Dao-di herb of Huangqin].

Zai-Wang Wu1, Zhe-Ming Wang, Yue Lu, Dan Wang, Rui-Qin Qian, Ming-Ying Shang, Xuan Wang, Shao-Qing Cai.   

Abstract

OBJECTIVE: To do some comparative study on anti-inflammatory and antipyretic effects between the Dao-di herb and non Dao-di herb of Huangqin (the roots of Scutellaria baicalensis) and provide thinking and evidence for study on geoherbalism and clinical usage of Huangqin.
METHOD: The anti-inflammatory action was assessed by auricular swelling induced by dimethylbenzene in mice and the antipyretic action was monitored by dried yeast-induced mice fever. RESULT: All samples of both Dao-di and non Dao-di herbs of Huangqin showed antipyretic effect. The Dao-di Huangqin samples showed antipyretic effect between 61% to 53% , whereas the non Dao-di Huangqin samples between 53% to 43%. Six Dao-di Huangqin samples showed better antipyretic effect than four non Dao-di Huangqin samples. All samples of both Dao-di and non Dao-di Huangqin showed anti-inflammatory effect. Dao-di Huangqin showed anti-inflammatory effect between 73% to 54%, whereas non dao-di Huangqin between 53% to 34%. Six Dao-di Huangqin showed better anti-inflammatory effect than four non Dao-di Huangqin. In totality, results from analysis of geoherbalism showed that geoherbal production areas of Huangqin had better effect than that of the non geoherbal production areas in anti-inflammatory and antipyretic effects.
CONCLUSION: Both the Dao-di and non Dao-di Huangqin have effects of anti-inflammatory and antipyretic to a certain extent, but the efficacy of the Dao-di Huangqin surpass the non Dao-di Huangqin.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23477153

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  2 in total

1.  Chinese herbal medicine bushen qinggan formula for blood pressure variability and endothelial injury in hypertensive patients: a randomized controlled pilot clinical trial.

Authors:  Chunxiao Wu; Jingchun Zhang; Yingke Zhao; Jing Chen; Yue Liu
Journal:  Evid Based Complement Alternat Med       Date:  2014-06-16       Impact factor: 2.629

Review 2.  Evidence-Based Study to Compare Daodi Traditional Chinese Medicinal Material and Non-Daodi Traditional Chinese Medicinal Material.

Authors:  Xingyue Yang; Xin Tian; Yannan Zhou; Yali Liu; Xinlong Li; Tingting Lu; Changhe Yu; Liyun He
Journal:  Evid Based Complement Alternat Med       Date:  2018-01-22       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.